These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 20730630)

  • 21. The Klotho gene family and the endocrine fibroblast growth factors.
    Kurosu H; Kuro-o M
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):368-72. PubMed ID: 18660672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring endocrine FGFs - structures, functions and biomedical applications.
    Phan P; Ternier G; Edirisinghe O; Kumar TKS
    Int J Biochem Mol Biol; 2024; 15(4):68-99. PubMed ID: 39309613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrine fibroblast growth factors as potential biomarkers for chronic kidney disease.
    Kondo Y; Komaba H; Fukagawa M
    Expert Rev Mol Diagn; 2020 Jul; 20(7):715-724. PubMed ID: 32513031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocrine fibroblast growth factors 15/19 and 21: from feast to famine.
    Potthoff MJ; Kliewer SA; Mangelsdorf DJ
    Genes Dev; 2012 Feb; 26(4):312-24. PubMed ID: 22302876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Klotho and endocrine fibroblast growth factors: markers of chronic kidney disease progression and cardiovascular complications?
    Kuro-O M
    Nephrol Dial Transplant; 2019 Jan; 34(1):15-21. PubMed ID: 29800324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of FGFs As Paracrine or Endocrine Signals in Liver Development, Health, and Disease.
    Itoh N; Nakayama Y; Konishi M
    Front Cell Dev Biol; 2016; 4():30. PubMed ID: 27148532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone-like fibroblast growth factors and metabolic regulation.
    Long YC; Kharitonenkov A
    Biochim Biophys Acta; 2011 Jul; 1812(7):791-5. PubMed ID: 21504790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21.
    Owen BM; Mangelsdorf DJ; Kliewer SA
    Trends Endocrinol Metab; 2015 Jan; 26(1):22-9. PubMed ID: 25476453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic roles of endocrine fibroblast growth factors.
    Fernandes-Freitas I; Owen BM
    Curr Opin Pharmacol; 2015 Dec; 25():30-5. PubMed ID: 26531325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c.
    Suzuki M; Uehara Y; Motomura-Matsuzaka K; Oki J; Koyama Y; Kimura M; Asada M; Komi-Kuramochi A; Oka S; Imamura T
    Mol Endocrinol; 2008 Apr; 22(4):1006-14. PubMed ID: 18187602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis.
    Wu X; Li Y
    Aging (Albany NY); 2009 Dec; 1(12):1023-7. PubMed ID: 20157585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mini-review: endocrine actions of fibroblast growth factor 19.
    Jones S
    Mol Pharm; 2008; 5(1):42-8. PubMed ID: 18179175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Fibroblast Growth Factors 19 and 21 in Bariatric Metabolism.
    Patton A; Khan FH; Kohli R
    Dig Dis; 2017; 35(3):191-196. PubMed ID: 28249286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands.
    Goetz R; Ohnishi M; Ding X; Kurosu H; Wang L; Akiyoshi J; Ma J; Gai W; Sidis Y; Pitteloud N; Kuro-O M; Razzaque MS; Mohammadi M
    Mol Cell Biol; 2012 May; 32(10):1944-54. PubMed ID: 22451487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression.
    Feng S; Dakhova O; Creighton CJ; Ittmann M
    Cancer Res; 2013 Apr; 73(8):2551-62. PubMed ID: 23440425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members.
    Goetz R; Beenken A; Ibrahimi OA; Kalinina J; Olsen SK; Eliseenkova AV; Xu C; Neubert TA; Zhang F; Linhardt RJ; Yu X; White KE; Inagaki T; Kliewer SA; Yamamoto M; Kurosu H; Ogawa Y; Kuro-o M; Lanske B; Razzaque MS; Mohammadi M
    Mol Cell Biol; 2007 May; 27(9):3417-28. PubMed ID: 17339340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective Regulation of FGF19 and FGF21 Expression by Cellular and Nutritional Stress.
    Shimizu M; Morimoto H; Maruyama R; Inoue J; Sato R
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(2):154-60. PubMed ID: 26052146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging Structure-Function Paradigm of Endocrine FGFs in Metabolic Diseases.
    Luo Y; Ye S; Li X; Lu W
    Trends Pharmacol Sci; 2019 Feb; 40(2):142-153. PubMed ID: 30616873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating fibroblast growth factors as metabolic regulators--a critical appraisal.
    Angelin B; Larsson TE; Rudling M
    Cell Metab; 2012 Dec; 16(6):693-705. PubMed ID: 23217254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circadian Regulation of Endocrine Fibroblast Growth Factors on Systemic Energy Metabolism.
    Yang Z; Zarbl H; Guo GL
    Mol Pharmacol; 2024 Feb; 105(3):179-193. PubMed ID: 38238100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.